|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：B317402 |
| 產(chǎn)品名稱：Bepafant-d8 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：10mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
B317402 |
| 名稱: |
Bepafant-d8 |
| 別名: |
4-[[6-(2-Chlorophenyl)-8,9-dihydro-1-methyl-4H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-8-yl]carbonyl]-morpholine-d8; 4H,7H-Cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine Morpholine derivatives-d8; Web 2170-d8 |
| 備用CAS: |
114776-28-2 unlabelled |
| 分子式: |
C??H??D?ClN?O?S |
| 分子量: |
476.02 |
| 類別: |
Building Blocks; Isotopic Labeled Analogues; |
| 應(yīng)用: |
Bepafant-d8 is labelled Bepafant (B317400), a selective hetrazepinoic antagonist of platelet activating factor (PAF). |
| 文獻(xiàn) |
|
|
|
|
?您的位置：
